First Manhattan’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Hold |
34,745
| – | – | ﹤0.01% | 680 |
|
|
2025
Q1 | $200K | Hold |
34,745
| – | – | ﹤0.01% | 648 |
|
|
2024
Q4 | $173K | Hold |
34,745
| – | – | ﹤0.01% | 659 |
|
|
2024
Q3 | $187K | Hold |
34,745
| – | – | ﹤0.01% | 656 |
|
|
2024
Q2 | $115K | Hold |
34,745
| – | – | ﹤0.01% | 647 |
|
|
2024
Q1 | $114K | Hold |
34,745
| – | – | ﹤0.01% | 750 |
|
|
2023
Q4 | $122K | Hold |
34,745
| – | – | ﹤0.01% | 730 |
|
|
2023
Q3 | $232K | Hold |
34,745
| – | – | ﹤0.01% | 634 |
|
|
2023
Q2 | $292K | Hold |
34,745
| – | – | ﹤0.01% | 590 |
|
|
2023
Q1 | $345K | Hold |
34,745
| – | – | ﹤0.01% | 577 |
|
|
2022
Q4 | $242K | Hold |
34,745
| – | – | ﹤0.01% | 654 |
|
|
2022
Q3 | $185K | Hold |
34,745
| – | – | ﹤0.01% | 708 |
|
|
2022
Q2 | $138K | Hold |
34,745
| – | – | ﹤0.01% | 785 |
|
|
2022
Q1 | $154K | Hold |
34,745
| – | – | ﹤0.01% | 807 |
|
|
2021
Q4 | $138K | Hold |
34,745
| – | – | ﹤0.01% | 818 |
|
|
2021
Q3 | $305K | Sell |
34,745
-1,001
| -3% | -$8.79K | ﹤0.01% | 660 |
|
|
2021
Q2 | $405K | Buy |
+35,746
| New | +$405K | ﹤0.01% | 599 |
|
|
2020
Q3 | – | Sell |
-350
| Closed | -$1K | – | 1324 |
|
|
2020
Q2 | $1K | Buy |
+350
| New | +$1K | ﹤0.01% | 1337 |
|